Abstract:Existing data acquisition modes such as full-scan, data-dependent (DDA), and data-independent acquisition (DIA) often present limited capabilities in capturing metabolic information in liquid chromatography-mass spectrometry (LC-MS)-based metabolomics. In this work, we proposed a novel metabolomic data acquisition workflow that combines DDA and DIA analyses to achieve better metabolomic data quality, including enhanced metabolome coverage, tandem mass spectrometry (MS2) coverage, and MS2 quality. This workflow, named data-dependent-assisted data-independent acquisition (DaDIA), performs untargeted metabolomic analysis of individual biological samples using DIA mode and the pooled quality control (QC) samples using DDA mode. This combination takes advantage of the high-feature number and MS2 spectral coverage of the DIA data and the high MS2 spectral quality of the DDA data. To analyze the heterogeneous DDA and DIA data, we further developed a computational program, DaDIA.R, to automatically extract metabolic features and perform streamlined metabolite annotation of DaDIA data set. Using human urine samples, we demonstrated that the DaDIA workflow delivers remarkably improved data quality when compared to conventional DDA or DIA metabolomics. In particular, both the number of detected features and annotated metabolites were greatly increased. Further biological demonstration using a leukemia metabolomics study also proved that the DaDIA workflow can efficiently detect and annotate around 4 times more significant metabolites than DDA workflow with broad MS2 coverage and high MS2 spectral quality for downstream statistical analysis and biological interpretation. Overall, this work represents a critical development of data acquisition mode in untargeted metabolomics, which can greatly benefit untargeted metabolomics for a wide range of biological applications.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.analchem.0c05022?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.analchem.0c05022</a>.Chemicals and solvents (Text S-1); LC-MS parameters settings (Text S-2); comparison of annotated metabolites in DDA, DIA, and DaDIA workflow (Text S-3); preparation of leukemia plasma samples (Text S-4); DaDIA R data processing parameter settings (Text S-5); details of dot product calculation (Text S-6); discussion of DaDIA.R processing speed (Text S-7); details of MS2 deconvolution (Text S-8); manual checking of raw data chromatograms (Figure S-1); (A) number and percentage of rescued features; (B) false-positive rates of rescued features in DaDIA data from urine sample analysis in RP(+) mode (Figure S-2); examples of the three different types of features (Figure S-3); overlapped features (A) and annotated metabolites (B) detected in DDA, DIA(SWATH), and DaDIA analysis in urine samples (Figure S-4); comparison of number and quantitative precision of the annotated metabolite in DDA, DIA(SWATH), and DaDIA data; (A) total number of annotated metabolites; (B) distribution of intensity RSDs (Figure S-5); comparison of MS2 mirror plots from DDA and uniquely detected endogenous metabolites in DaDIA with similar dot product (DP) (Figure S-6); false-positive rates of statistically significant features in the DDA and DaDIA data in the biological application (Figure S-7); pathway analysis results of the leukemia plasma samples (Figure S-8); summary of all of the endogenous metabolites from urine samples in the DaDIA method (Table S-1); summary of unique endogenous metabolites annotated from urine DaDIA data (Table S-2); summary of annotated metabolites and significantly dysregulated metabolites from the leukemia plasma samples (Table S-3) (<a class="ext-link" href="/doi/suppl/10.1021/acs.analchem.0c05022/suppl_file/ac0c05022_si_001.pdf">PDF</a>)DaDIA_demo.zip: mzXML files of DDA and DIA(SWATH) data and an. msp library for practicing DaDIA.R DaDIA MS2 mirror plots (<a class="ext-link" href="/doi/suppl/10.1021/acs.analchem.0c05022/suppl_file/ac0c05022_si_002.zip">ZIP</a>)Zip file of all of the MS2 mirror plots generated from the urine DaDIA data (<a class="ext-link" href="/doi/suppl/10.1021/acs.analchem.0c05022/suppl_file/ac0c05022_si_003.zip">ZIP</a>)This article has not yet been cited by other publications.

Development of a method for dansylation of metabolites using organic solvent-compatible buffer systems for amine/phenol submetabolome analysis

Development of High-Performance Chemical Isotope Labeling LC-MS for Profiling the Human Fecal Metabolome.

Dansylation Isotope Labeling Liquid Chromatography Mass Spectrometry for Parallel Profiling of Human Urinary and Fecal Submetabolomes.

Stable isotope N-phosphoryl amino acids labeling for quantitative profiling of amine-containing metabolites using liquid chromatography mass spectrometry

Isotope labelled in suit derivatization-extraction integrated system for amine/phenol submetabolome analysis based on nanoconfinement effect: Application to lung cancer

An Extendable All-in-one Injection Twin Derivatization LC-MS/MS Strategy for the Absolute Quantification of Multiple Chemical-Group-based Submetabolomes.

Stepwise solid phase extraction integrated with chemical derivatization for all-in-one injection LC-MS/MS analysis of metabolome and lipidome

Integration of Chemical Derivatization and in-Source Fragmentation Mass Spectrometry for High-Coverage Profiling of Submetabolomes

Annotation of Dipeptides and Tripeptides Derivatized Via Dansylation Based on Liquid Chromatography-Mass Spectrometry and Iterative Quantitative Structure Retention Relationship.

Development of a Data-Independent Targeted Metabolomics Method for Relative Quantification Using Liquid Chromatography Coupled with Tandem Mass Spectrometry.

Development of Chemical Isotope Labeling Liquid Chromatography Orbitrap Mass Spectrometry for Comprehensive Analysis of Dipeptides

A Novel Approach for Lc-Ms/Ms-Based Chiral Metabolomics Fingerprinting and Chiral Metabolomics Extraction Using A Pair of Enantiomers of Chiral Derivatization Reagents

Profiling and quantification of aminophospholipids based on chemical derivatization coupled with HPLC-MS

Strategy for Nontargeted Metabolomic Annotation and Quantitation Using a High-Resolution Spectral-Stitching Nanoelectrospray Direct-Infusion Mass Spectrometry with Data-Independent Acquisition

Isotope labelling--paired homologous double neutral loss scan-mass spectrometry for profiling of metabolites with a carboxyl group.

Simultaneous 3-Nitrophenylhydrazine Derivatization Strategy of Carbonyl, Carboxyl and Phosphoryl Submetabolome for LC-MS/MS-Based Targeted Metabolomics with Improved Sensitivity and Coverage.

DaDIA: Hybridizing Data-Dependent and Data-Independent Acquisition Modes for Generating High-Quality Metabolomic Data

Improved Annotation of Untargeted Metabolomics Data through Buffer Modifications That Shift Adduct Mass and Intensity

Development of data-independent acquisition workflows for metabolomic analysis on a quadrupole-orbitrap platform

Comprehensive Profiling of Amine-Containing Metabolite Isomers with Chiral Phosphorus Reagents

Metabolic analysis of four phenolic acids in rat by liquid chromatography-tandem mass spectrometry.